N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide

C93H105F13N32O14S5 — CID 158419229

About N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide

N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide (PubChem CID 158419229) has the molecular formula C93H105F13N32O14S5 and a molecular weight of 2302.38 g/mol. Its IUPAC name is N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide.

Molecular Properties

• Compound Name: N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide
• PubChem CID: 158419229
• Molecular Formula: C93H105F13N32O14S5
• Molecular Weight: 2302.38 g/mol
• Exact Mass: 2300.69
• IUPAC Name: N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide
• SMILES: CN(CC1CC(O)CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1)S(C)(=O)=O.COC1CC(CNS(C)(=O)=O)CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1.CS(=O)(=O)CC1CCCN(c2cc(-c3cnc4ccc(C(F)(F)F)nn34)ccn2)C1.CS(=O)(=O)NCC1CN(c2cc(-c3cnc4ccc(C(F)(F)F)nn34)ccn2)CCO1.C[C@H]1COC(CNS(C)(=O)=O)CN1c1cc(-c2cnc3ccc(C(F)(F)F)nn23)ncn1
• InChI: InChI=1S/C19H20F3N5O2S.2C19H23F2N7O3S.C18H20F3N7O3S.C18H19F3N6O3S/c1-30(28,29)12-13-3-2-8-26(11-13)18-9-14(6-7-23-18)15-10-24-17-5-4-16(19(20,21)22)25-27(15)17;1-26(32(2,30)31)8-12-5-13(29)10-27(9-12)18-6-15(23-11-24-18)16-7-22-17-4-3-14(19(20)21)25-28(16)17;1-31-13-5-12(7-25-32(2,29)30)9-27(10-13)18-6-15(23-11-24-18)16-8-22-17-4-3-14(19(20)21)26-28(16)17;1-11-9-31-12(6-25-32(2,29)30)8-27(11)17-5-13(23-10-24-17)14-7-22-16-4-3-15(18(19,20)21)26-28(14)16;1-31(28,29)24-9-13-11-26(6-7-30-13)17-8-12(4-5-22-17)14-10-23-16-3-2-15(18(19,20)21)25-27(14)16/h4-7,9-10,13H,2-3,8,11-12H2,1H3;3-4,6-7,11-13,19,29H,5,8-10H2,1-2H3;3-4,6,8,11-13,19,25H,5,7,9-10H2,1-2H3;3-5,7,10-12,25H,6,8-9H2,1-2H3;2-5,8,10,13,24H,6-7,9,11H2,1H3/t;;;11-,12?;/m...0./s1
• InChIKey: HAGZSYGRTJJYCQ-ZRJOPSFBSA-N
• XLogP: 8.70
• TPSA: 528.22 Ų
• H-Bond Donors: 4
• H-Bond Acceptors: 42
• Rotatable Bonds: 27
• Heavy Atoms: 157
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2302.38
LogP ≤ 5	8.70
H-Bond Donors ≤ 5	4
H-Bond Acceptors ≤ 10	42

Frequently Asked Questions

What is the IUPAC name of N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide?

The IUPAC name of N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide (CID 158419229) is N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide.

What is the SMILES notation for N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide?

The canonical SMILES for N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide is CN(CC1CC(O)CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1)S(C)(=O)=O.COC1CC(CNS(C)(=O)=O)CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1.CS(=O)(=O)CC1CCCN(c2cc(-c3cnc4ccc(C(F)(F)F)nn34)ccn2)C1.CS(=O)(=O)NCC1CN(c2cc(-c3cnc4ccc(C(F)(F)F)nn34)ccn2)CCO1.C[C@H]1COC(CNS(C)(=O)=O)CN1c1cc(-c2cnc3ccc(C(F)(F)F)nn23)ncn1.

What is the InChIKey of N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide?

The InChIKey is HAGZSYGRTJJYCQ-ZRJOPSFBSA-N. The full InChI is InChI=1S/C19H20F3N5O2S.2C19H23F2N7O3S.C18H20F3N7O3S.C18H19F3N6O3S/c1-30(28,29)12-13-3-2-8-26(11-13)18-9-14(6-7-23-18)15-10-24-17-5-4-16(19(20,21)22)25-27(15)17;1-26(32(2,30)31)8-12-5-13(29)10-27(9-12)18-6-15(23-11-24-18)16-7-22-17-4-3-14(19(20)21)25-28(16)17;1-31-13-5-12(7-25-32(2,29)30)9-27(10-13)18-6-15(23-11-24-18)16-8-22-17-4-3-14(19(20)21)26-28(16)17;1-11-9-31-12(6-25-32(2,29)30)8-27(11)17-5-13(23-10-24-17)14-7-22-16-4-3-15(18(19,20)21)26-28(14)16;1-31(28,29)24-9-13-11-26(6-7-30-13)17-8-12(4-5-22-17)14-10-23-16-3-2-15(18(19,20)21)25-27(14)16/h4-7,9-10,13H,2-3,8,11-12H2,1H3;3-4,6-7,11-13,19,29H,5,8-10H2,1-2H3;3-4,6,8,11-13,19,25H,5,7,9-10H2,1-2H3;3-5,7,10-12,25H,6,8-9H2,1-2H3;2-5,8,10,13,24H,6-7,9,11H2,1H3/t;;;11-,12?;/m...0./s1.

What are the key properties of N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide?

N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide has a molecular weight of 2302.38 g/mol, XLogP of 8.70, 27 rotatable bonds, 4 hydrogen bond donors, and 42 hydrogen bond acceptors.

Where does this data come from?

All data for N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-hydroxypiperidin-3-yl]methyl]-N-methylmethanesulfonamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5-methoxypiperidin-3-yl]methyl]methanesulfonamide;3-[2-[3-(methylsulfonylmethyl)piperidin-1-yl]-4-pyridinyl]-6-(trifluoromethyl)imidazo[1,2-b]pyridazine;N-[[(5S)-5-methyl-4-[6-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]morpholin-2-yl]methyl]methanesulfonamide;N-[[4-[4-[6-(trifluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]morpholin-2-yl]methyl]methanesulfonamide is sourced from PubChem (CID 158419229), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).